Perceptive Advisors’s Medline Inc MDLN Stock Holding History

Perceptive Advisors’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.25M	Hold	28,000	–	–	0.02%	88
2025 Q4	$1.18M	Buy	+28,000	New	+$1.18M	0.02%	108

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $3.85B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Perceptive Advisors's MDLN Position: Q1 2026 in Review

Perceptive Advisors held its Medline Inc (MDLN) position steady in Q1 2026 at 28,000 shares worth $1.25M. The position accounts for 0.02% of the portfolio, ranked #88.

Perceptive Advisors first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Perceptive Advisors held 28,000 shares of Medline Inc worth $1.25M as of Q1 2026.
Perceptive Advisors left its Medline Inc share count unchanged in Q1 2026.
Medline Inc made up 0.02% of Perceptive Advisors's portfolio in Q1 2026, its #88 holding.
Perceptive Advisors first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.